69644人已查看 《JOURNAL OF THROMBOSIS AND THROMBOLYSIS》 期刊2024最新IF预测值
预警说明查看说明
时间
预警情况
2024年02月发布的2024版
不在预警名单中
2023年01月发布的2023版
不在预警名单中
2021年12月发布的2021版
不在预警名单中
2020年12月发布的2020版
不在预警名单中
2025年预警名单预测
无异常数据 期刊预警概率很低
结果仅供参考
*来源:中科院《 国际期刊预警名单》
中科院分区查看说明
版本
大类学科
小类学科
Top期刊
综述期刊
2023年12月最新升级版
医学3区
HEMATOLOGY
血液学
3区
PERIPHERAL VASCULAR DISEASE
外周血管病
4区
CARDIAC & CARDIOVASCULAR SYSTEMS
心脏和心血管系统
4区
否
否
2022年12月升级版
医学4区
HEMATOLOGY
血液学
4区
PERIPHERAL VASCULAR DISEASE
外周血管病
4区
CARDIAC & CARDIOVASCULAR SYSTEMS
心脏和心血管系统
4区
否
否
2021年12月升级版
医学4区
HEMATOLOGY
血液学
4区
PERIPHERAL VASCULAR DISEASE
外周血管病
4区
CARDIAC & CARDIOVASCULAR SYSTEMS
心脏和心血管系统
4区
否
否
2021年12月升级版
医学4区
HEMATOLOGY
血液学
4区
PERIPHERAL VASCULAR DISEASE
外周血管病
4区
CARDIAC & CARDIOVASCULAR SYSTEMS
心脏和心血管系统
4区
否
否
2020年12月升级版
医学4区
HEMATOLOGY
血液学
4区
PERIPHERAL VASCULAR DISEASE
外周血管病
4区
CARDIAC & CARDIOVASCULAR SYSTEMS
心脏和心血管系统
4区
否
否
JCR分区
WOS分区等级:Q2区
版本
按学科
分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of
Science)为每个学科内的期刊按照IF数值排序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2022-2023年最新版)
HEMATOLOGY
Q2
PERIPHERAL VASCULAR DISEASE
Q2
CARDIAC & CARDIOVASCULAR SYSTEMS
Q2
测一测你投这本期刊的成功率
【官方推荐】国内首个期刊投稿预测系统,多维度分析投稿成功率,助你精准决策
12500
人已预测
期刊介绍
The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.
Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study
来源期刊:Journal of Thrombosis and Thrombolysis
DOI:10.1007/s11239-019-01923-9
Assessment of the reporting quality of RCTs for novel oral anticoagulants in venous thromboembolic disease based on the CONSORT statement
来源期刊:Journal of Thrombosis and Thrombolysis
DOI:10.1007/s11239-019-01931-9
Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients
来源期刊:Journal of Thrombosis and Thrombolysis
DOI:10.1007/s11239-019-01876-z
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care
来源期刊:Journal of Thrombosis and Thrombolysis
DOI:10.1007/s11239-019-01962-2
“Blueprinting” thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke
来源期刊:Journal of Thrombosis and Thrombolysis
DOI:10.1007/s11239-019-01813-0
已经到底了~
测一测你投这本期刊的成功率
【官方推荐】国内首个期刊投稿预测系统,多维度分析投稿成功率,助你精准决策
12500
人已预测
鹿粉126744
2019-10-06 12:28:28
这次和临床合作一起写的一篇病例报告加综述 "severe pulmonary tuberculosis complicated with insidious pulmonary thromboembolism. a case report and literature review". 投稿2天,直接accept!非常快。